Considerations for head and neck oncology practices during the coronavirus disease 2019 (COVID-19) pandemic: Wuhan and Toronto experience.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32338807.
- Also identified by DOI 10.1002/hed.26205 and PMC identifier 7267482.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The practices of head and neck surgical oncologists must evolve to meet the unprecedented needs placed on our health care system by the Coronavirus disease 2019 (COVID-19) pandemic. Guidelines are emerging to help guide the provision of head and neck cancer care, though in practice, it can be challenging to operationalize such recommendations. Head and neck surgeons at Wuhan University faced significant challenges in providing care for their patients. Similar challenges were faced by the University of Toronto during the severe acute respiratory syndrome (SARS) pandemic in 2003. Herein, we outline our combined experience and key practical considerations for maintaining an oncology service in the midst of a pandemic.
Medical subject headings
- Communicable Disease Control
- Coronavirus Infections
- Head and Neck Neoplasms
- Pandemics
- Pneumonia, Viral
- Practice Guidelines as Topic
- Surgical Oncology